Page last updated: 2024-09-03

4'-hydroxydiclofenac and Cancer of Prostate

4'-hydroxydiclofenac has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dalton, JT; Lu, Y; Steiner, MS; Zhou, D	1

Other Studies

1 other study(ies) available for 4'-hydroxydiclofenac and Cancer of Prostate

Article	Year
Cytochrome P-450 2C9 sensitizes human prostate tumor cells to cyclophosphamide via a bystander effect. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:10 Topics: Antineoplastic Agents, Alkylating; Aryl Hydrocarbon Hydroxylases; Biotransformation; Blotting, Western; Cell Survival; Cyclophosphamide; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Diclofenac; Humans; Kinetics; Male; Prodrugs; Prostatic Neoplasms; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tumor Cells, Cultured	2000

Article

Year

Cytochrome P-450 2C9 sensitizes human prostate tumor cells to cyclophosphamide via a bystander effect.

Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:10

Topics: Antineoplastic Agents, Alkylating; Aryl Hydrocarbon Hydroxylases; Biotransformation; Blotting, Western; Cell Survival; Cyclophosphamide; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Diclofenac; Humans; Kinetics; Male; Prodrugs; Prostatic Neoplasms; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tumor Cells, Cultured

2000